Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls

Nikolaos Vitoratos, Aikaterini Deliveliotou, Nikos F. Vlahos, George Mastorakos, Konstantinos Papadias, Dimitrios Botsis, George K. Creatsas

Research output: Contribution to journalArticle

Abstract

Aims. To investigate changes in serum adiponectin during pregnancy and postpartum and assess its relationship with insulin resistance as measured by homeostasis model assessment (HOMA-IR). Methods. Twenty-two normal pregnant women were compared with 22 women diagnosed with gestational diabetes mellitus (GDM). Serum adiponectin levels were measured at the time of the glucose challenge test as well as in the immediate postpartum period and the correlation of adiponectin to HOMA-IR was performed. Results. Adiponectin was significantly lower in women with GDM than in controls during pregnancy (5381 vs. 8449 ng/dl, p = 0.004), as well as postpartum (3278 vs. 6958 ng/ml, p = 0.002). A significant reduction in adiponectin (3278 vs. 5381 ng/ml, p = 0.002) was observed postpartum in GDM women but not in controls. Using a lower cut-off value of 5253 ng/ml, maternal adiponectin could exclude GDM with a sensitivity of 86.4% and a specificity of 59.1% (area under the curve = 0.752, standard error = 0.77, 95% confidence interval 0.601-0.903, p = 0.004). Adiponectin levels during pregnancy were negatively correlated with HOMA-IR (r = -0.375, p = 0.012). Conclusion. GDM is associated with decreased serum adiponectin levels both in pregnancy as well as postpartum. Adiponectin is negatively correlated to HOMA-IR. A reduction in maternal adiponectin after delivery indicates a significant placental contribution to adiponectin production.

Original languageEnglish (US)
Pages (from-to)614-619
Number of pages6
JournalGynecological Endocrinology
Volume24
Issue number11
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Gestational Diabetes
Adiponectin
Postpartum Period
Pregnancy
Serum
Mothers
Area Under Curve
Insulin Resistance
Pregnant Women
Homeostasis
Confidence Intervals

Keywords

  • Adiponectin
  • Gestational diabetes
  • Homeostasis model assessment
  • Insulin resistance

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Obstetrics and Gynecology

Cite this

Vitoratos, N., Deliveliotou, A., Vlahos, N. F., Mastorakos, G., Papadias, K., Botsis, D., & Creatsas, G. K. (2008). Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. Gynecological Endocrinology, 24(11), 614-619. https://doi.org/10.1080/09513590802342866

Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. / Vitoratos, Nikolaos; Deliveliotou, Aikaterini; Vlahos, Nikos F.; Mastorakos, George; Papadias, Konstantinos; Botsis, Dimitrios; Creatsas, George K.

In: Gynecological Endocrinology, Vol. 24, No. 11, 2008, p. 614-619.

Research output: Contribution to journalArticle

Vitoratos, N, Deliveliotou, A, Vlahos, NF, Mastorakos, G, Papadias, K, Botsis, D & Creatsas, GK 2008, 'Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls', Gynecological Endocrinology, vol. 24, no. 11, pp. 614-619. https://doi.org/10.1080/09513590802342866
Vitoratos, Nikolaos ; Deliveliotou, Aikaterini ; Vlahos, Nikos F. ; Mastorakos, George ; Papadias, Konstantinos ; Botsis, Dimitrios ; Creatsas, George K. / Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls. In: Gynecological Endocrinology. 2008 ; Vol. 24, No. 11. pp. 614-619.
@article{92524d58433c49f0be27a0d1b70b9d2f,
title = "Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls",
abstract = "Aims. To investigate changes in serum adiponectin during pregnancy and postpartum and assess its relationship with insulin resistance as measured by homeostasis model assessment (HOMA-IR). Methods. Twenty-two normal pregnant women were compared with 22 women diagnosed with gestational diabetes mellitus (GDM). Serum adiponectin levels were measured at the time of the glucose challenge test as well as in the immediate postpartum period and the correlation of adiponectin to HOMA-IR was performed. Results. Adiponectin was significantly lower in women with GDM than in controls during pregnancy (5381 vs. 8449 ng/dl, p = 0.004), as well as postpartum (3278 vs. 6958 ng/ml, p = 0.002). A significant reduction in adiponectin (3278 vs. 5381 ng/ml, p = 0.002) was observed postpartum in GDM women but not in controls. Using a lower cut-off value of 5253 ng/ml, maternal adiponectin could exclude GDM with a sensitivity of 86.4{\%} and a specificity of 59.1{\%} (area under the curve = 0.752, standard error = 0.77, 95{\%} confidence interval 0.601-0.903, p = 0.004). Adiponectin levels during pregnancy were negatively correlated with HOMA-IR (r = -0.375, p = 0.012). Conclusion. GDM is associated with decreased serum adiponectin levels both in pregnancy as well as postpartum. Adiponectin is negatively correlated to HOMA-IR. A reduction in maternal adiponectin after delivery indicates a significant placental contribution to adiponectin production.",
keywords = "Adiponectin, Gestational diabetes, Homeostasis model assessment, Insulin resistance",
author = "Nikolaos Vitoratos and Aikaterini Deliveliotou and Vlahos, {Nikos F.} and George Mastorakos and Konstantinos Papadias and Dimitrios Botsis and Creatsas, {George K.}",
year = "2008",
doi = "10.1080/09513590802342866",
language = "English (US)",
volume = "24",
pages = "614--619",
journal = "Gynecological Endocrinology",
issn = "0951-3590",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - Serum adiponectin during pregnancy and postpartum in women with gestational diabetes and normal controls

AU - Vitoratos, Nikolaos

AU - Deliveliotou, Aikaterini

AU - Vlahos, Nikos F.

AU - Mastorakos, George

AU - Papadias, Konstantinos

AU - Botsis, Dimitrios

AU - Creatsas, George K.

PY - 2008

Y1 - 2008

N2 - Aims. To investigate changes in serum adiponectin during pregnancy and postpartum and assess its relationship with insulin resistance as measured by homeostasis model assessment (HOMA-IR). Methods. Twenty-two normal pregnant women were compared with 22 women diagnosed with gestational diabetes mellitus (GDM). Serum adiponectin levels were measured at the time of the glucose challenge test as well as in the immediate postpartum period and the correlation of adiponectin to HOMA-IR was performed. Results. Adiponectin was significantly lower in women with GDM than in controls during pregnancy (5381 vs. 8449 ng/dl, p = 0.004), as well as postpartum (3278 vs. 6958 ng/ml, p = 0.002). A significant reduction in adiponectin (3278 vs. 5381 ng/ml, p = 0.002) was observed postpartum in GDM women but not in controls. Using a lower cut-off value of 5253 ng/ml, maternal adiponectin could exclude GDM with a sensitivity of 86.4% and a specificity of 59.1% (area under the curve = 0.752, standard error = 0.77, 95% confidence interval 0.601-0.903, p = 0.004). Adiponectin levels during pregnancy were negatively correlated with HOMA-IR (r = -0.375, p = 0.012). Conclusion. GDM is associated with decreased serum adiponectin levels both in pregnancy as well as postpartum. Adiponectin is negatively correlated to HOMA-IR. A reduction in maternal adiponectin after delivery indicates a significant placental contribution to adiponectin production.

AB - Aims. To investigate changes in serum adiponectin during pregnancy and postpartum and assess its relationship with insulin resistance as measured by homeostasis model assessment (HOMA-IR). Methods. Twenty-two normal pregnant women were compared with 22 women diagnosed with gestational diabetes mellitus (GDM). Serum adiponectin levels were measured at the time of the glucose challenge test as well as in the immediate postpartum period and the correlation of adiponectin to HOMA-IR was performed. Results. Adiponectin was significantly lower in women with GDM than in controls during pregnancy (5381 vs. 8449 ng/dl, p = 0.004), as well as postpartum (3278 vs. 6958 ng/ml, p = 0.002). A significant reduction in adiponectin (3278 vs. 5381 ng/ml, p = 0.002) was observed postpartum in GDM women but not in controls. Using a lower cut-off value of 5253 ng/ml, maternal adiponectin could exclude GDM with a sensitivity of 86.4% and a specificity of 59.1% (area under the curve = 0.752, standard error = 0.77, 95% confidence interval 0.601-0.903, p = 0.004). Adiponectin levels during pregnancy were negatively correlated with HOMA-IR (r = -0.375, p = 0.012). Conclusion. GDM is associated with decreased serum adiponectin levels both in pregnancy as well as postpartum. Adiponectin is negatively correlated to HOMA-IR. A reduction in maternal adiponectin after delivery indicates a significant placental contribution to adiponectin production.

KW - Adiponectin

KW - Gestational diabetes

KW - Homeostasis model assessment

KW - Insulin resistance

UR - http://www.scopus.com/inward/record.url?scp=56749152145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56749152145&partnerID=8YFLogxK

U2 - 10.1080/09513590802342866

DO - 10.1080/09513590802342866

M3 - Article

VL - 24

SP - 614

EP - 619

JO - Gynecological Endocrinology

JF - Gynecological Endocrinology

SN - 0951-3590

IS - 11

ER -